Mast cells are primary effector cells of immediate hypersensitivity, and may be involved in host defense, tissue homeostasis and other forms of hypersensitivity. The current proposal extends work that originated with the identification of two types of human mast cells based on their protease phenotypes and the finding that stem cell factor enables human mast cells to develop in vitro from hematopoietic progenitors.
Aim 1 examines new functional and phenotypic characteristics that distinguish MCT (tryptase+/chymase-) from MCTC (tryptase+/chymase-)types of human mast cells. These include: for MCTC cells- functional expression of cell-surface CD88, IL-6-mediated upregulation of chymase protein/mRNA in only MCTC cells, and proliferation of only MCTC cells in serum-free media; for MCT cells- mechanism by which IL-6makes MCT cells resist apoptosis to IL-4, failure of lung MCT cells to convert to MCTC cells, and evaluation of new genes expressed in only MCT cells (including their expression in nasal and bronchial mucosa of atopic rhinitis and asthma subjects).
Aim 2 examines the activation of skin-derived MCTC cells through FcyRIIA as well as FceRI. Degradation of cytokines by proteases released from the same MCTC cells will be studied in vitro, and the in vivo consequences considered. Whether IgG immune-complexes activate human MCTC cells will be determined in vitro. Finally, the functional impact of increased FceRI levels on mature MCTC cells caused by IgE will be assessed in vitro as well as in vivo.
Aim 3 will test whether Th1 and Th2 type cytokines modulate mediator production by human mast cells. The mechanisms by which Th1 and/or Th2 cytokines induce LTC4 and enhance PGD2 production by activated skin MCTC cells will be examined. Whether FcyRI expression by IFN-y-primed MCTC cells enhances the response to IgG immune complexes or to CRP will be determined. Finally, the functional impact of upregulating cytokine receptors such as IL-4R on skin MCTC cells will be assessed. These studies will extend known phenotypic differences between different types of human mast cells to important functional features, reveal new paradigms for mast cell activation, and lead to a better understanding of their role(s) in human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027517-18
Application #
7371125
Study Section
Special Emphasis Panel (ZRG1-III-L (08))
Program Officer
Dong, Gang
Project Start
1988-12-01
Project End
2010-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
18
Fiscal Year
2008
Total Cost
$319,343
Indirect Cost
Name
Virginia Commonwealth University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Le, Quang Trong; Lotfi-Emran, Sahar; Min, Hae-Ki et al. (2014) A simple, sensitive and safe method to determine the human ?/?-tryptase genotype. PLoS One 9:e114944
Ward, Brant R; Arslanian, Silva A; Andreatta, Elisa et al. (2012) Obesity is not linked to increased whole-body mast cell burden in children. J Allergy Clin Immunol 129:1164-6
Alvarez-Twose, I; Vano-Galvan, S; Sanchez-Munoz, L et al. (2012) Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 67:813-21
Le, Quang T; Gomez, Gregorio; Zhao, Wei et al. (2011) Processing of human protryptase in mast cells involves cathepsins L, B, and C. J Immunol 187:1912-8
Le, Quang T; Min, Hae-Ki; Xia, Han-Zhang et al. (2011) Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C. J Immunol 186:7136-43
Teodosio, Cristina; García-Montero, Andrés C; Jara-Acevedo, María et al. (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125:719-26, 726.e1-726.e4
Zhao, Wei; Gomez, Gregorio; Yu, Shao-Hua et al. (2008) TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. J Immunol 181:7263-72
Fukuoka, Yoshihiro; Xia, Han-Zhang; Sanchez-Munoz, Laura B et al. (2008) Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol 180:6307-16
Sabato, M Fernanda; Irani, Anne-Marie; Bukaveckas, Bonny L et al. (2008) A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysis. J Mol Diagn 10:258-64
Gomez, Gregorio; Jogie-Brahim, Sherryline; Shima, Mika et al. (2007) Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells. J Immunol 179:1353-61

Showing the most recent 10 out of 56 publications